1. Angiotensin II receptor blockers;Barreras A;Proc (Bayl Univ Med Cent),2003
2. Management of hypertension using olmesartan alone or in combination;Zhang X;Cardiol Ther,2017
3. Olmesartan. drug usage statistics, United States, 2013 - 2020. (2022). Accessed: June 20, 2023: https://clincalc.com/DrugStats/Drugs/Olmesartan.
4. Sprue-like enteropathy associated with olmesartan: a new kid on the enteropathy block;Hujoel IA;GE Port J Gastroenterol,2016
5. FDA drug safety communication. FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil. (2019). Accessed: June 8, 2023: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-label-changes-inclu....